Please enable JS

YOU ARE

A SPONSOR / CRO

Success is when the time to access an innovative treatment is reduced.

Get more informations

Optimize patient recruitment for your clinical trials

By providing CT-SCOUT™ to your clinical sites you will both facilitate their contribution to your studies and get a better overview of the site recruitment activities for your studies. You can also further enlarge your patient reach by providing ToTem4me to referral sites, with no need to train them on your studies.

THE PATIENT JOURNEY

Telemedicine Technologies favors direct contact with patients (with the medical team via ct-scout) and (with an expert clinical trial coordinator via ToTem4me) to involve them wherever they are and empower them to make the decision to participate in a clinical trial.

Through a questionnaire based on a powerful and reliable algorithm, you can pre-select qualified patients for your trial.

A coordinator is made available to the patient following registration on ToTem4me to follow up with the patient before, during and after inclusion in a clinical trial. A notification is sent to the clinical research team once a pest has been detected on CT-SCOUT™.

Get more information

Looking for innovative digital solutions to optimize patient recruitment in IBD trials

Read the post

Testimonials

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »

Prof Stéphane Nancey
Hepato-gastroenterology department,
Lyon-Sud University Hospital

« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,

Prof Laurent Peyrin-Biroulet
President, GETAID and ECCO

LATEST NEWSOUR NEWS >

telemedecine technologies news

Electronic Signatures in Clinical Trials – EUCROF Webinar

September 18, 2025

September 25 – 11am – 12:30pm CEST •The meeting will start at 11.00AM o’clock.•Audio is available either through your computer or through phone connection (dial-in).•Your line will be kept on mute.•At the end, there will be time for questions and you can submit your questionsthrough the ‘question’ box.•After the webinar, connect to the EUCROF eLearnIN […]

READ MORE
telemedecine technologies news

Telemedicine Technologies at BioWin Days 2025

September 18, 2025

September 23 – Namur, Belgium – Booths 26–27 Welcome to BioWin Day ! The premiere venue for doing business with Belgian health professionals, innovators and industry leaders. Explore new partnerships, see what’s evolving in biopharma and health-tech, and get a clear view of how a country as small as Belgium produces world-changing healthcare solutions. What […]

READ MORE
telemedecine technologies news

PDA 2025: Leveraging AI for GxP Compliance in Drug Production

September 18, 2025

Biopharm International The bio/pharmaceutical industry is undergoing a significant digital shift, with artificial intelligence (AI) playing an increasingly vital role in achieving operational excellence and bolstering quality maturity. A strategic and well-governed approach to AI adoption is not merely an advantage but a necessity for enhancing efficiency while maintaining rigorous good practices (GxP) compliance, said […]

READ MORE